InspireMD (NSPR) Cash from Operations Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33.55% |
| Sep 30, 2025 | -23.18% |
| Jun 30, 2025 | -41.23% |
| Mar 31, 2025 | -30.15% |
| Dec 31, 2024 | -33.90% |
| Sep 30, 2024 | -25.10% |
| Jun 30, 2024 | -8.49% |
| Mar 31, 2024 | -7.76% |
| Dec 31, 2023 | -18.30% |
| Sep 30, 2023 | -17.19% |
| Jun 30, 2023 | -8.67% |
| Mar 31, 2023 | -22.10% |
| Dec 31, 2022 | -12.47% |
| Sep 30, 2022 | -20.51% |
| Jun 30, 2022 | -14.35% |
| Mar 31, 2022 | -8.43% |
| Dec 31, 2021 | -9.05% |
| Sep 30, 2021 | -6.98% |
| Jun 30, 2021 | -26.06% |
| Mar 31, 2021 | -14.32% |
| Dec 31, 2020 | 0.15% |
| Jun 30, 2020 | 9.35% |
| Mar 31, 2020 | 12.62% |
| Mar 31, 2019 | 1.24% |
| Sep 30, 2018 | 10.98% |
| Jun 30, 2018 | 13.39% |
| Mar 31, 2018 | 8.77% |
| Dec 31, 2017 | 12.41% |
| Sep 30, 2017 | 3.15% |
| Mar 31, 2017 | -11.80% |
| Dec 31, 2016 | 14.91% |
| Sep 30, 2016 | -7.43% |
| Jun 30, 2016 | 11.04% |
| Mar 31, 2016 | -38.88% |
| Dec 31, 2015 | -31.87% |